drugset
drugset / Trial / NCT05198778

A Safety, PK, PD and Food Effect Study of URC102 in Healthy Adults and Patients With Renal Impairment

NCT05198778 ↗

Phase 1 Completed 28 enrolled JW Pharmaceutical
Non-randomizedParallel-groupOpen-labelTreatment

Summary

A phase 1 clinical trial to evaluate safety, PK/PD profiles and food effects of URC102 in patients with renal impairment and healthy people.

Timeline

Start
2021-11-29
Primary completion
2022-07-13
Completion
2022-07-13

Drugs

EvaluationDrugModalityDoseRoute
Subject URC102 Unknown — Oral

Indications

hypouricemia, renal